Virta Health Argues Type 2 Diabetes Can Be Reversed at Scale

Sami Inkinen says his original view of obesity, prediabetes, and type 2 diabetes was blunt and, in retrospect, embarrassing: people knew what to do, failed to do it, and then imposed enormous costs on the healthcare system. He was an endurance athlete, lean, highly disciplined, and judgmental enough to believe metabolic disease was mostly a failure of personal control.

That view collapsed around 2012, near the time Trulia went public, when Inkinen says he discovered that despite being roughly 10% body fat, exercising about 15 hours a week, and competing successfully as a triathlete, he was prediabetic and “on my way to type 2 diabetes.” He had completed Hawaii Ironman World Championship races, won a triathlon age-group world championship, and had spent much of his life as a cross-country skier, biathlete, and endurance athlete. The diagnosis forced the question he says changed his thinking: if he could not avoid becoming metabolically unhealthy, what chance did the average person have?

His answer is that poor metabolic health is not caused by people waking up and deciding to gain 200 pounds, develop type 2 diabetes, and inject insulin for years. Food and nutrition are still, in his account, the central drivers — but the failure is not laziness. It is a food environment that “slowly but surely poisons us,” coupled with care systems that generally manage progression with more medication rather than systematically reversing the underlying state.

Inkinen describes the poor metabolic state in practical terms: high glucose, high fasting insulin, insulin resistance, a body primarily burning sugar, constant hunger, and constant cravings, often even in people carrying substantial excess body fat. The visible diagnoses may be type 2 diabetes, obesity, cardiovascular disease, fatty liver disease, chronic kidney disease, or other conditions. But the substrate, as he describes it, is impaired metabolic health.

He cited figures meant to frame the scale of the problem: more than 50% of American adults have prediabetes or type 2 diabetes, and a peer-reviewed figure he referenced says 93% of American adults are metabolically unhealthy in one way or another. A related article excerpt displayed during the discussion summarized a 2022 report stating that only 6.8% of American adults had optimal metabolic health, using measures including waist circumference, blood pressure, fasting glucose and HbA1c, triglycerides, HDL cholesterol, and medication status.

Inkinen rejects the idea that his own prediabetes was simply a rare genetic case. Genes matter, he says, but the American gene pool has not changed quickly enough to explain a country in which roughly 60% of adults have type 2 diabetes or prediabetes and the overwhelming majority have at least one marker of poor metabolic health. He also stresses that leanness is not protection. A person can be “skinny and lean and metabolically unhealthy,” especially in some populations where major weight gain may not accompany insulin resistance.

His retrospective diagnosis of his own diet is specific: for more than a decade, he says, he ate six meals a day, extremely high in carbohydrates, very high on glycemic index, and almost devoid of fat. He was not describing Twinkies. He named rice, bread, apples, granola bars, ketchup, pasta, juice, and similar foods. He estimates that as an endurance athlete he might consume 4,000 calories a day, with 3,000 coming from carbohydrates — roughly 750 grams of carbs a day. In his phrasing, he was “drip feeding sugar” into his veins constantly.

The point is not that apples and bread are equivalent as foods in every respect. Inkinen’s point is that anything carrying glucose molecules ultimately affects blood sugar, and that dose matters. Fiber slows absorption, but in the context of very high daily carbohydrate intake, constant feeding, hunger, and insulin resistance, he believes the pattern was sufficient to impair his metabolic health despite high exercise volume.

He says he was hungry for 15 years as an athlete. If he ate to appetite, he would gain fat; if he restricted, he remained hungry. That experience is part of why he presents Virta Health’s model not as calorie restriction with better branding, but as an attempt to change the biology that drives hunger, cravings, glucose, insulin, and weight.

Tim Ferriss pressed Inkinen on what Virta’s intervention actually looks like, especially because many ketogenic or low-carbohydrate approaches fail not at theory but at adherence. A Virta Quick Guide used in the discussion set out the starting structure: “Curb your Carbohydrates,” aim initially around 30 grams per day, measure total carbs rather than net carbs, and build meals around non-starchy vegetables, moderate protein, added fat, salt, and extras. The guide gave concrete targets: five servings per day of non-starchy vegetables; roughly 4–5 ounces of protein per meal for women and 6–8 ounces for men; fats such as olive oil, avocado oil, butter, coconut oil, cream cheese, heavy cream, and sour cream; and supplemental sodium as advised by the care team.

Inkinen accepts the broad characterization that Virta reduces carbohydrates to address and reverse insulin resistance, but he resists calling the protocol simply “keto.” Virta uses its own individualized nutrition protocol, he says, because generic labels create predictable failure modes: people Google the label, find versions they like or hate, and often execute it incorrectly. The therapy, in his account, is individualized nutrition delivered with clinical monitoring, coaching, medical supervision, and constant adjustment.

He compares nutrition as therapy to drug dosing. Virta has dose-response curves, he says, showing that the more effectively patients reduce total carbohydrate intake, the better the typical outcomes. But the company does not treat perfection as the threshold for success. Patients can land at different points on the curve and still improve. “We never want to let perfection be the enemy of progress,” he says. The point is to give people enough understanding and support to make workable choices rather than demand one rigid dietary identity.

Inkinen says this is harder than nuclear physics, even though he trained as a physicist and began his career at a nuclear power plant. A drug can be prescribed in a fixed dose. Food is different: every person makes a medical decision three or four times a day, every day differs from the next, and every patient’s preferences, constraints, and starting metabolic state differ.

That complexity is why Virta is built as a virtual care model rather than a pamphlet. Patients may use continuous glucose monitors or finger-prick devices, depending on the situation. Labs are drawn once or twice a year. Virta monitors biomarkers remotely, tracks blood ketones, blood glucose, weight, and other data, and uses physicians and coaches to adjust care. Inkinen says Virta has the largest dataset in the world for metabolic disease reversal, with millions of patient-years and daily patient-level data points that include biomarkers, not just qualitative reporting.

The intervention’s success, he argues, depends on fitting the nutrition protocol to real lives. A vegan is not going to be persuaded to eat bacon and eggs. A truck driver whose lunch is McDonald’s is not going to be told to shop at Whole Foods or Erewhon and cook at home. Inkinen’s example was deliberately stark: if the patient’s world is McDonald’s, Virta will try to reverse diabetes on a McDonald’s diet.

Virta’s quick-start plate is therefore a structure, not a cuisine. The company attempts to personalize the implementation: what foods the patient will actually eat, what restaurants they use, what dietary rules they will not violate, what level of carbohydrate reduction is realistic, and how the care team can keep improving the result.

Inkinen also described AI-enabled tools that help at the decision point. A patient in a restaurant or kitchen can take a picture and receive immediate guidance about what adjustment to make, tied to their actual situation. He used a self-driving car analogy: a car that only goes straight works until the first corner. One-size-fits-all diets fail for the same reason. The therapy has to handle turns.

Inkinen says Virta’s most surprising finding is not that highly motivated or highly educated patients can improve. It is that, in Virta’s analyses, outcomes appear similar across groups he initially expected to differ. Virta works with Native American tribes, roughly 800 large employers, truck drivers, and other populations. Inkinen says the company has analyzed outcomes by Area Deprivation Index — a way of comparing geographic deprivation — and seen the same outcomes. He says the same is true across race and ethnicity, at large scale.

His conclusion is that if the biology is fixed, the outcomes follow. He frames this as a direct rebuke to the idea that patients need moral reform or extra willpower training because they are busy, poor, less educated, or living in food deserts. The task is to change the metabolic state and support the daily decisions that keep it changed.

He gave the example of a patient who has had type 2 diabetes for 15 years, uses 100 units of insulin per day, and injects insulin three times a day. Virta, he says, can reverse that state in six to nine months and sustain it long term. He cited average one-year weight loss of 13% on an intent-to-treat basis, meaning the average is calculated from the whole enrolled group rather than only the successes. In the clinical trial he referenced, that translated to about 30 pounds on average, and DEXA scans showed the loss was mostly fat.

Inkinen also cited effects beyond blood sugar and weight. He says Virta has shown up to a 75% reduction in liver disease, referring to conditions now called MASH and MASLD. He also said these diseases cost the United States $100 billion a year, and that the one FDA-approved drug for MASH costs $45,000 per year. Virta, he says, delivers similar results nutritionally. Those figures were presented as Inkinen’s claims in the discussion.

The pancreatic-cancer claim was presented with unusual caution because of the disease and the stakes. The discussion referenced a ClinicalTrials Arena article titled “Virta Health reports improved outcomes in pancreatic cancer trial,” and an American Cancer Society journal page for “A randomized phase II trial of gemcitabine, nab-paclitaxel, cisplatin with or without a medically supervised ketogenic diet for patients with metastatic pancreatic cancer,” first published March 12, 2026.

Inkinen described the trial as a well-controlled randomized controlled trial run with academic oncology centers. One arm received three chemotherapy drugs; the other received the same drugs plus Virta nutrition therapy. In stage four metastatic pancreatic cancer, which he described as extremely deadly and typically diagnosed late, he says the combination arm showed about 35% life extension on average.

He emphasized the limits of that claim: the disease remains deadly, and the benefit is counted in months, not a shift from 12 months to 12 years. He did not claim nutrition cures cancer. He said some cancers appear to thrive in a poor metabolic environment, and that the trial illustrates how much may be downstream of metabolic health.

Ferriss, who also stressed neither man is a medical doctor, connected the claim to the idea that some cancers are glycolytic and dependent on sugar metabolism, while noting this does not apply to all cancers. The exchange stayed within caution: metabolic health may affect cancer outcomes in some settings; Virta’s pancreatic cancer trial is presented as one example; it is not a universal cancer claim.

Inkinen does not frame GLP-1 drugs as bad medicine. He says Virta providers prescribe oral and injectable GLP-1s when appropriate and when the employer, health plan, or other plan sponsor covers them. He calls GLP-1s a real innovation in obesity and metabolic disease, far better than earlier generations of diet pills.

His concern is that GLP-1s change how much people eat, not necessarily what they eat. They reduce appetite, but if the underlying diet does not change, stopping the drug often leads to weight regain. Inkinen says Virta has shown, in published peer-reviewed data, that patients who come in on GLP-1s and discontinue them can sustain weight loss 18 months out when nutrition changes during care. A PubMed page referenced during the discussion was titled “Impact of Glucagon-Like Peptide 1 Agonist Deprescription in Type 2 Diabetes in a Real-World Setting: A Propensity Score Matched Cohort Study.”

He also says 80% of Virta patients surveyed while on GLP-1s reported that they wanted either to severely reduce dependence on the drugs or get off them completely. He uses that to challenge the press narrative that Americans simply want to take pills indefinitely. Given a choice, he argues, many people would rather be healthy without medication.

The adherence comparison is central to his argument. Inkinen says Virta patients — “real Americans, not Samis” — have 83% adherence or retention at one year. He contrasts that with publicly available GLP-1 adherence data, which he characterizes as roughly 30% to 50% or 40% to 50% at one year.

Why would a nutrition intervention outperform a medication on adherence? Inkinen’s answer is perceived benefit. Patients experience weight loss, improved energy, reduced medication burden, and sometimes insulin elimination. He described patient stories in plain terms: a 65-year-old who did not expect to see grandchildren grow up, now gardening for the first time in 20 years; someone no longer needing to inject insulin. By contrast, calorie restriction often feels like suffering today for a short-term appearance payoff later.

He also draws a basic distinction between healthy food and medication: healthy nutrition has no drug side-effect profile. He acknowledges GLP-1s are tolerated much better than many drugs, but mentions nausea and stomach issues, and notes concerns about lean body mass loss in older populations. His stance is not “nutrition only.” It is that drugs can help, but without changing the food environment and metabolic state, the result may remain dependent on indefinite pharmacology.

Ferriss repeatedly returned to edge cases because that is where diet systems often reveal whether they are practical. A vegan patient, in his view, might be harder to fit into a low-carbohydrate program than a McDonald’s customer, because many vegan products marketed as healthy are highly glycemic processed foods. Inkinen’s answer was not to abandon the protocol, but to individualize it.

Protein is usually not the macronutrient Virta changes most for the average patient, he says. Standard American diets are often roughly adequate in protein, and protein is the most expensive macronutrient. But in vegan diets, adequate protein is often the hardest part. He gave a minimum target of about 1.2 grams of protein per kilogram of lean or normal body weight. For an 80-kilogram person — about 176 pounds — that means roughly 100 grams of protein per day.

Vegan patients may rely on tofu, nuts, soy, dairy if acceptable, eggs if acceptable, and other sources, depending on what they are willing to eat. Inkinen also notes that protein does not store itself in the body the way fat and carbohydrate can, so it generally needs to be consumed two or three times a day to maintain body mass.

After protein, the challenge becomes replacing high-glycemic vegan junk food with healthier fats and less starchy vegetables. Inkinen disputes the idea that this is automatically more expensive because corn syrup and sugar calories are subsidized. He argues that calorie-for-calorie, healthy fat can be inexpensive: one liter of high-quality olive oil from Costco contains about 9,000 calories, he said, and can replace cheap sugar calories at similar cost. He also notes that in a person who is very overweight, the goal is not necessarily to replace every calorie removed, because the body can supply fat calories.

A Virta patient story referenced in the discussion was titled “Vegan and loving it: Virta gives me plenty of support and options,” written by Bill, a Virta patient diagnosed with type 2 diabetes in 2004. A second Virta excerpt showed Bill’s favorite recipes, including “Celery and Five Spiced Tofu,” with a note that tofu can be a protein source for vegans doing keto-style eating.

Inkinen’s summary is that vegan execution is “totally manageable,” though it often means throwing out “crap vegan food.” His examples included sugar-frosted cornflakes and orange juice. He said he loves oranges, but called orange juice “essentially soda.”

Ferriss then sharpened the distinction between reducing glycemic load and entering technical ketosis. A truck driver eating lettuce-wrapped cheeseburgers and Diet Coke might reach measurable blood ketones within days. A vegan patient eating tofu and tempeh while keeping total carbs low might improve metabolic health without becoming deeply ketotic. Inkinen agreed with the underlying point and explained again why Virta avoids the “keto” label. The clinical target is not identity purity. It is improved metabolic health along a dose-response curve.

Inkinen’s professional and athletic output is presented as less a triumph of heroic will than a system of defaults. He still spends about 15 minutes every Sunday planning the coming week. He lists the three things that “absolutely have to get done,” professionally and personally, then schedules key items, including workouts. He says structure allows flexibility and spontaneity; without structure, things disappear between the cracks.

He is running Virta Health at about 1,000 employees, raising young children, staying married, and training as what he calls a semi-athlete. For that life, he says, unscheduled good intentions do not survive. His advice to a younger high performer veering toward burnout would start with something deliberately simple: sit down for five minutes on Sunday evening, write down the one or two things that absolutely must get done the next week, and put them in the calendar. If possible, block the first two morning hours for that work. Then turn off notifications and do not let the universe control the day.

He keeps a plain text file with the hierarchy: four things to remember as CEO now and 20 years from now, three things for the year, and three things for the week. He updates it every Sunday. He also has a 15-year personal plan, updated annually, which he says he stumbled into and has found extremely helpful. Without that higher-level architecture, Sunday planning degenerates into asking whether to write a book, change jobs, or do a project a boss requested. With the architecture, the weekly list has a North Star.

His week is batched by cognitive mode when circumstances permit. Monday is for group and leadership meetings, including whole-company and leadership-team contexts. Tuesday is for one-on-ones, which he says are important but draining as an introvert. His number of direct reports has varied over time — 15, 10, eight for a long period, and recently only two — because he adjusts the structure to what the company needs that year. Wednesday is reserved by default for thinking and writing. Thursday and Friday are more often internal client work and less rigidly structured.

The Wednesday writing includes a weekly CEO team letter. Inkinen says he has written 553 of them. One example was “Team Letter #111: How to build a great career at Virta?” dated August 30, 2017, with sections including “Why do we do this?”, “People, the most important,” and “Topic of the week.”

The format is part standard structure and part essay. He begins with a patient quote to remind employees why the company exists. He includes business metrics, growth, priorities, and annual objectives. Then he writes a “topic of the week,” which may address external context, career advice, internal events, or strategy. He gave GLP-1 drugs as a real example of an external development that required explanation: how the drugs might change patient care and affect Virta’s business.

Inkinen says the letters scale because an email takes the same time whether it reaches five inboxes or 1,000. It lets him give context, explain external and internal changes, and create a sense of connection across the company. He also sees the writing as a personal outlet; with more than 530 essays, he joked that a book could be created by uploading them to ChatGPT.

His thinking rarely happens at the desk. The creative work happens during workouts, walks, and other low-input periods. During COVID, he realized he had filled 100% of workouts with podcasts, audiobooks, and music, and that problem-solving and creativity had nearly stopped. He now limits consumption during workouts to at most half the time. If the brain is always in consumption mode, he says, the background processing does not happen. When ideas arise, he emails himself notes or stores them for Wednesday, when he turns them into written output.

When Ferriss asked how Inkinen would intervene with a young superstar headed toward burnout, Inkinen separated planning from resilience. Planning protects attention. Resilience, in his formula, requires four elements.

First is foundational metabolic health: sleep, nutrition, and exercise. Inkinen believes that if a knowledge worker is metabolically very unhealthy, the odds of cracking under pressure increase. This is not positioned as a productivity hack but as the physiological base for tolerating stress.

Second is having two or three identities or outlets. For Inkinen, those are husband and parent, CEO, and “wannabe athlete.” They do not all go well at once. In fact, he says they are never all simultaneously “rocking.” The value is psychological diversification: when work is bad, the kids may still love him that day; when athletic life is frustrating, the company or family may be stable. He contrasts that with younger founders who proudly have only one thing and are willing to die for the company. That can feel noble when the company is winning, but the first serious setback can make everything collapse.

Third is having peers outside the company with whom one can speak candidly. For Inkinen, that has been YPO, the Young Presidents’ Organization, since around 2008. He says CEOs need spaces where they can “let your hair down” and say things they cannot say in front of employees.

Fourth is understanding how the mind works. He does not prescribe a single tool. It could be meditation or something else. His practical point is that if a person is completely attached to their thoughts, eventually those thoughts will “get” them. You cannot necessarily think yourself out of the hole you thought yourself into. Some ability to step back and observe the mind having “a life of its own” has helped him stay above water through 26 years of building fast-growth companies, from his first software company in April 2000 through Virta in 2026.

He added a caveat repeatedly: he has not cracked yet, but it could happen tonight. He is careful not to claim immunity. He only says the toolkit has worked so far, and that he has not used prescription drugs for mind-related issues.

The underlying pattern is consistent with his broader worldview. Saying no is not deprivation for him; it is liberation. People often call focus sacrifice, especially when looking at Olympic athletes or founders. Inkinen thinks that narrative is wrong. If the focused activity fills the cup, then refusing the 99% of “normal” distractions is not loss. It is the price of a more satisfying life. He says he is happier married to one person than five, and happier running one company than several.

On non-travel days, Inkinen wakes by 5:00 a.m.; the morning of the interview, his alarm was 4:45. He says he has the unusual privilege of being able to roll out of bed and jump into a lake or pond immediately. It is not a long swim — maybe a minute, a few strokes, cold water — but he compares it to a freezing shower. The mountain water may be around 40 degrees.

After the water, still dripping wet, he does a few minutes of air squats, jumps, core work, supermans, leg raises, and pushups. He does the core work because he races bicycles and has lower-back issues. If core work does not happen before his brain boots up, he says, it will not happen. The whole initial sequence takes roughly five to ten minutes.

His explanation is not scientific performance optimization; it is practical mood management. “Mood follows movement and motion,” he says. Before he has time to ruminate about back pain, workload, or worry, he has been in cold water, moved, and raised his heart rate.

Then he tries to do something useful for other people. At home that means preparing coffee for his wife and emptying the dishwasher. Fifteen minutes after waking, he has moved, served someone else, and avoided the first wave of self-focused rumination.

After that he has espresso or coffee while the house is still quiet. He records sleep in an online spreadsheet that now contains 16 years of data, and writes three things he is grateful for. He deliberately focuses on mundane things: leaves in aspen trees, warm temperature, ordinary details. Then he works for about an hour, clearing email and Slack or writing. When his wife wakes up, they spend 15 or 20 minutes having coffee and talking. His main workout generally happens between 6:30 and 8:30 a.m., unless time-zone meetings force a change.

He has repeated versions of this routine for more than a decade. When people ask for the science behind it, his answer is deliberately ungrand: if it does not feel good, it is not right for you; if it feels good, repeat it.

Ferriss asked Inkinen to think like a coach for a reluctant endurance trainee: someone who understands the healthspan case for aerobic work and VO2 max, but hates stationary cycling, has back issues, and does not want to road bike in traffic. Inkinen’s answer started with basics: progressive overload and specificity. If there is no progressive overload, adaptation stops. If the training does not match the desired capacity, it will not transfer well.

But he also rejects needless punishment. To build cardiovascular capacity, the body has to burn oxygen and raise heart rate, but the modality can vary. Cycling is common because it is low impact, safe indoors, and space-efficient. For someone with back issues, he recommends getting a bike fit from someone who understands physical therapy and can set up the bike for the actual body in question, not for aerodynamics. Handlebars can be high; standing intervals can be used; comfort matters.

He also suggested snow-based and low-impact alternatives: Nordic skiing, uphill skinning, swimming, speed walking uphill, and Nordic walking with poles. Poles can add roughly 10 heartbeats per minute, he says, and turn an uphill walk into a larger aerobic stimulus. Ferriss, who dislikes stationary biking, responded especially positively to skinning and swimming.

On VO2 max, Inkinen estimates that a fit 30-year-old male might be around 35 to 45 milliliters per kilogram per minute. His own measured VO2 max was over 80 a couple of years earlier, though he expects it may be lower now at age 50 because VO2 max declines with age. He says 85 to 90 can put an endurance athlete near Olympic-podium territory, while above 90 means one should probably be competing rather than doing podcasts.

For targeted VO2 max training, Inkinen says adaptation comes quickly and the work can also burn people out. Common sessions include 30 seconds hard, 30 seconds easy repeated, or two- to four-minute very hard efforts with about three minutes recovery, repeated four or five times. He might do two such workouts a week for a three-week block before a race — six workouts total — then drop to a lower maintenance dose, perhaps one every two weeks. He warns against constantly pushing VO2 max; once someone approaches their ceiling, more pressure can mean injury and burnout rather than continued gains.

That anti-heroic view extends to endurance dogma. Ferriss brought up an old Inkinen blog post titled “Hacking Your Run: 10% Faster in Four Weeks,” in which Inkinen described preparing for a half-Ironman-distance triathlon while 20 pounds overweight and much slower than usual. His protocol averaged only one hour and 55 minutes of running per week. It included 10–15 minutes of running almost every day to develop muscular endurance, one weekly all-out 10-by-one-minute treadmill interval set, and about five minutes of plyometrics three times a week. Inkinen wrote that this took about 40 seconds per mile, roughly 10%, off his best running speed in four weeks — at a time when a 5% annual improvement would normally be considered a huge jump.

Inkinen’s explanation is that he broke running performance into contributing parts. He needed enough muscular endurance that his legs would not collapse under 13.1 miles of pounding. He needed cardiovascular stimulus. He needed efficiency. He did not need conventional high running mileage if a multi-sport approach could build the aerobic engine with less impact.

He is skeptical of the endurance practice of accumulating fatigue for six, eight, or 12 weeks, tapering for two or three weeks, and hoping to emerge from the hole on race day. In the last four or five years he competed seriously in triathlon, he shifted toward being almost ready to race at the end of every week. Hard workouts were still hard, and progressive overload still mattered, but by Wednesday he wanted to be capable of hitting strong numbers again after a hard weekend. He compares it to lifting: if bench press numbers drop for three straight weeks, lifters immediately suspect under-recovery or under-fueling. Endurance athletes often normalize the same pattern as discipline.

His Ironman example is meant to show how far this can go. He has completed more than 10 full-distance Ironmans, with a fastest time of 8 hours 24 minutes as an amateur, and ran a 2:56 marathon after the swim and bike. Yet his longest training run for those performances was usually about one hour and 20 minutes, roughly nine or ten miles. For a triathlete, he believes the cardiovascular engine can be built through low-impact modalities such as cycling while running is used more specifically and sparingly.

Inkinen and his wife, Meredith Loring, rowed from California to Hawaii in an unsupported ocean rowboat. The shortest distance from Monterey to Waikiki is about 2,400 nautical miles, but because the weather did not cooperate, Inkinen says they rowed roughly 2,750 nautical miles. The crossing took 45 days and three hours. There were no helicopters, no follow boats, and no outside support dropping supplies.

Ferriss cited a USA Today article describing a formal written and signed document the couple prepared before the row. The document covered not only how they would treat each other during the trip, but how they would respond to specific complaints and gripes. Ferriss joked that the only thing more Inkinen than rowing almost 3,000 miles was having a document for it.

Inkinen says the document served two purposes. First, during preparation, it made explicit that both of them were fully committed. The row was not a two-week adventure one could casually enter; he says preparation was a half-time job for six months, requiring physical training and safety practice, including learning how to use survival gear. The document was partly a commitment not to give up.

Second, it governed behavior on the boat. Its most important rule was that once any decision was made, it was water under the bridge. They had to make constant decisions about safety, navigation, angle, weather, and daily tactics, and they could never know with certainty whether a decision had been optimal. On land, a couple might disagree, go to work, and forget it. In a small, stinking boat for 45 days, there were endless opportunities to relitigate. The rule prevented that.

The row also created an amount of uninterrupted time that Inkinen says changed their lives. They slept six or seven hours a day, leaving roughly 18 hours together with nowhere to go, no bathroom to retreat to, no bedroom door to close. Some time was silent. Some was filled with questions. At one point, his wife asked which of their friends he would marry if not her. Inkinen, “as a diligent engineer,” answered by going friend by friend and landing on a specific person. He says no married or unmarried person should answer that question. His wife responded that the person he chose was the last one she would have picked.

More consequentially, they decided on the boat to have children. Before the trip, both had been convinced life was too good to “destroy it with children.” About seven to ten days in, after stormy conditions and enough mental space to think, Inkinen says he had something like a lightning strike: starting more companies or attaching his name to a hospital did not answer the question of what was worthy of life. Raising a child suddenly did. He told his wife, and she said she had been thinking exactly the same thing for the previous 24 hours.

Asked why the change happened there, Inkinen’s best explanation is clarity without distraction. No email, no job, no tasks, no to-dos — only space. He speculates that the mind’s priors can become rigid and that, in some contexts, they loosen enough for a person to see or feel a decision differently. The biggest decisions, he says, are ultimately subjective: whom to marry, whether to have children, what a life is for. He once had a spreadsheet for choosing a spouse, but after meeting his wife, he threw it out.

Inkinen’s frugality is not presented as asceticism for its own sake. Ferriss cited a Forbes article saying Inkinen did not own a car until he was 36, rented cheap cars from Thrifty, had not bought a watch in 15 years, wore race swag for exercise clothes, and kept a casual wardrobe of repeated T-shirts and jeans. Inkinen’s explanation is the same as his explanation for focus: less choice can be liberating.

He says he likes not cluttering life with money, possessions, or decisions that do not matter. The car story illustrates the point. After Stanford, he had no American credit and needed a car for work. Thrifty would rent him one for about $19 a day. He traveled so much that the arrangement became convenient: no washing, no oil changes, no maintenance, and when a rental was broken into twice in San Francisco, he could drive it back to the airport and leave with another car. His default rental was a Ford Escape.

Years later, his wife decided he needed to own a car because he was an adult. She bought him the same Ford Escape he had been renting for years, in blue. He had not been refusing a car as a symbol; renting had simply been simpler.

His principle for money is “the less I have to think about it, the happier I am.” Early financial success was valuable because it covered house, food, and leftovers. But if the leftovers require ongoing thought, he sees that as a problem. Spending is worthwhile when it buys time, reduces friction, or improves the living environment in ways that support the life he actually wants — for example, being able to exercise easily or roll into a lake from the house. He has fancy bicycles because they matter to the sport he cares about. He does not care similarly about cars, watches, or wardrobe variety.

Inkinen’s closing professional claim is direct: the chronic-and-progressive model of metabolic disease is wrong. He says the common view — that type 2 diabetes, obesity, cardiovascular disease, and related conditions can only be managed with ever-increasing medication — is fundamentally false. Whether through Virta or other approaches, he wants people with type 2 diabetes to know the condition can be reversed systematically, not miraculously.

He is careful not to blame physicians. In his account, doctors are well-meaning, but medical school gives them essentially no nutrition training — “zero or 0.5 hours” — and they are not taught that type 2 diabetes can be reversed at scale. Patients therefore often do not hear that message from the healthcare system, even when reversal may be possible.

Virta’s customer, as he defines it, is anyone who pays healthcare costs in America: self-insured employers, health plans taking financial risk, Medicare Advantage, managed Medicaid organizations, state employee groups, and government entities such as VA or DOD. He says Virta works with around 800 self-insured employers and 13 of 50 state employee groups. The pitch to payers is intentionally economic: Virta can help them make money by reducing the cost of sickness. Inkinen calls dollars “the love language of American capitalism,” and says the side benefit is saving lives.

Ferriss’s assessment is that Virta has built something he was not sure could be built: individualized metabolic care with mass-scale adherence, large datasets, trials, cohort analysis, and practical flexibility. He emphasized that the power of the model is partly its escape from purity. A rigid “you must be ketogenic and hit a specific blood concentration” approach will not work at mass scale. But if patients can improve 5%, 10%, 20%, or 50% through individualized changes they can sustain, the cumulative health effect can be large.

Inkinen’s final posture is not triumphalist. Virta is 11 years in the making, about 1,000 employees, and still growing. “Bigger company, bigger problems,” he says. But the central message he wants carried is hope without blame: metabolic disease is not a character defect, and reversal does not require suffering as the organizing principle. It requires changing the food signal, supporting the person’s actual life, and treating nutrition with the seriousness usually reserved for drugs.